Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
6.84
+0.08 (1.18%)
Sep 5, 2025, 2:45 PM CST
SHE:002252 Revenue
Shanghai RAAS Blood Products had revenue of 1.95B CNY in the quarter ending June 30, 2025, a decrease of -11.37%. This brings the company's revenue in the last twelve months to 7.88B, down -5.28% year-over-year. In the year 2024, Shanghai RAAS Blood Products had annual revenue of 8.18B with 2.67% growth.
Revenue (ttm)
7.88B
Revenue Growth
-5.28%
P/S Ratio
5.74
Revenue / Employee
2.35M
Employees
3,350
Market Cap
45.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.18B | 212.50M | 2.67% |
Dec 31, 2023 | 7.96B | 1.40B | 21.27% |
Dec 31, 2022 | 6.57B | 2.28B | 53.16% |
Dec 31, 2021 | 4.29B | 1.53B | 55.26% |
Dec 31, 2020 | 2.76B | 176.70M | 6.84% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |